Rock Creek Pharmaceuticals Inc (RCPIQ)

OTC Markets
0.003
0.00(0.00%)
  • Volume:
    992,646
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    0.003 - 0.004

RCPIQ Overview

Prev. Close
0.003
Day's Range
0.003-0.004
Revenue
-
Open
0.003
52 wk Range
0.001-0.015
EPS
-0.78
Volume
992,646
Market Cap
511.33K
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
500,826
P/E Ratio
-
Beta
3.17
1-Year Change
200%
Shares Outstanding
170,444,758
Next Earnings Date
Aug 12, 2021
What is your sentiment on Rock Creek Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Rock Creek Pharmaceuticals Inc News

Rock Creek Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyNeutral
Technical IndicatorsNeutralNeutralNeutralBuyBuy
SummaryBuyBuyBuyBuyNeutral

Rock Creek Pharmaceuticals Inc Company Profile

Rock Creek Pharmaceuticals Inc Company Profile

Employees
5

Rock Creek Pharmaceuticals, Inc. is a pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. The Company's activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine. The Company has completed Phase I safety studies of its product candidate in Europe. In pre-clinical testing, anatabine demonstrates anti-inflammatory activity in a range of in vitro and in vivo assays.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.